Metamfetamine
- Generic Name
- Metamfetamine
- Brand Names
- Desoxyn
- Drug Type
- Small Molecule
- Chemical Formula
- C10H15N
- CAS Number
- 537-46-2
- Unique Ingredient Identifier
- 44RAL3456C
- Background
Metamfetamine (methamphetamine) is a psychostimulant and sympathomimetic drug, and a member of the amphetamine group of sympathomimetic amines. Methamphetamine can induce effects such as euphoria, increased alertness and energy, and enhanced self-esteem. It is a scheduled drug in most countries due to its high potential for addiction and abuse.
...
- Indication
For the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity.
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Refractory exogenous obesity
- Associated Therapies
- -
Pilot Study of Entacapone for Methamphetamine Abuse
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-02-11
- Last Posted Date
- 2019-09-12
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 29
- Registration Number
- NCT02058966
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Buspirone as a Candidate Medication for Methamphetamine Abuse
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-04-30
- Last Posted Date
- 2018-02-07
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 9
- Registration Number
- NCT01843205
- Locations
- 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath